Next Article in Journal
Enhanced Ocular Anti-Aspergillus Activity of Tolnaftate Employing Novel Cosolvent-Modified Spanlastics: Formulation, Statistical Optimization, Kill Kinetics, Ex Vivo Trans-Corneal Permeation, In Vivo Histopathological and Susceptibility Study
Previous Article in Journal
Population Pharmacokinetics and Dose Optimization Based on Renal Function of Rivaroxaban in Thai Patients with Non-Valvular Atrial Fibrillation
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(8), 1745; https://doi.org/10.3390/pharmaceutics14081745
Action Date Notes Link
article pdf uploaded. 21 August 2022 16:12 CEST Version of Record https://www.mdpi.com/1999-4923/14/8/1745/pdf-vor
article supplementary file uploaded. 21 August 2022 16:12 CEST - https://www.mdpi.com/1999-4923/14/8/1745#supplementary
article xml file uploaded 23 August 2022 11:19 CEST Original file -
article xml uploaded. 23 August 2022 11:19 CEST Update https://www.mdpi.com/1999-4923/14/8/1745/xml
article pdf uploaded. 23 August 2022 11:19 CEST Updated version of record https://www.mdpi.com/1999-4923/14/8/1745/pdf
article html file updated 23 August 2022 11:21 CEST Original file -
article html file updated 24 August 2022 21:16 CEST Update https://www.mdpi.com/1999-4923/14/8/1745/html
Back to TopTop